A decision, likely to come in June, would be a major victory for the FDA’s authority to regulate prescription drugs and for abortion-rights advocates who have sought to protect access to mifepristone.
Related Posts
Trump promises a ‘deal’ on abortion that will please everyone. It likely doesn’t exist.
Should Trump appear vague or duck the issue, some of his supporters fear it will allow the Biden campaign to tie him to the more […]
Five takeaways from the Milken Institute Future of Health Summit
Here are POLITICO’s top takeaways from the summit: Advanced AI can improve care — but it comes with challenges. AI was the hottest topic of […]
Dr. Oz on the future of Medicaid, Trump’s megabill and AI avatar health care
The Conversation with Dasha Burns launches with Mehmet Oz as its first guest.